Skip to main content

Latest SEC Filings — Page 150

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

Twist Bioscience Reports Record Q2 Revenue, Raises Full-Year Guidance, and Reaffirms Path to Profitability
Form 8-KTWST · Form 8-K · 6d ago
Superior Group of Companies Reports Q1 Profit Turnaround, Reaffirms Full-Year Guidance
Form 8-KSGC · Form 8-K · 6d ago
Mako Mining Intersects High-Grade Gold, Extending Permitted Mining Area at Las Conchitas
ProForm 6-KMAKO · Form 6-K · 6d ago
Axsome Therapeutics Reports Strong Q1 Revenue Growth and Key Pipeline Advancements
ProForm 8-KAXSM · Form 8-K · 6d ago
BioCryst Secures $70M Upfront in European Navenibart Licensing Deal, Up to $275M in Milestones
ProForm 8-KBCRX · Form 8-K · 6d ago
Krystal Biotech Reports Exceptional Q1 Growth Driven by VYJUVEK Global Expansion and Robust Pipeline Progress
ProForm 10-QKRYS · Form 10-Q · 6d ago
ADMA Biologics Secures FDA Approval for ASCENIV Label Expansion to Pediatric Patients
ProForm 8-KADMA · Form 8-K · 6d ago
Cogent Communications Reports Mixed Q1 2026 Results with EPS Beat and Improved Cash Flow
Form 8-KCCOI · Form 8-K · 6d ago
CNS Pharmaceuticals Secures $22.5M in Highly Dilutive Private Offering at Deep Discount
ProForm 8-KCNSP · Form 8-K · 6d ago
Apellis Pharmaceuticals to be Acquired by Biogen Inc.
ProForm 8-KAPLS · Form 8-K · 6d ago
GameStop Proposes $55.5 Billion Acquisition of eBay, Citing $2 Billion in Synergies
ProForm 425GME · Form 425 · 6d ago
GameStop Proposes $55.5 Billion Acquisition of eBay, Outlines Major Cost Synergies
ProForm 8-KGME · Form 8-K · 6d ago
Nasdaq Issues Delisting Notice to Calisa Acquisition Corp for Non-Compliance with Minimum Holder Rule
ProForm 8-KALIS · Form 8-K · 6d ago
Indivior Initiates $175M Accelerated Share Repurchase Under Existing Program
ProForm 8-KINDV · Form 8-K · 6d ago
MicroCloud Hologram Announces CEO and Director Transition
Form 6-KHOLO · Form 6-K · 6d ago
GameStop Officially Offers to Acquire eBay for $55.5 Billion, $125/Share in Cash & Stock
ProForm SCHEDULE 13DGME · Form SCHEDULE 13D · 6d ago
Cushman & Wakefield Subsidiary to Redeem $100 Million of Senior Secured Notes
ProForm 8-KCWK · Form 8-K · 6d ago
Aura Biosciences Announces Proposed Public Offering of Stock and Warrants, Including Conditional Repurchase of 10.8% Stake from Matrix Capital
ProForm 424B5AURA · Form 424B5 · 6d ago
Norwegian Cruise Line Lowers Full-Year Guidance Amid Geopolitical Headwinds and Booking Challenges
ProForm 8-KNCLH · Form 8-K · 6d ago
Apollo Funds Divest Entire ADT Stake in Secondary Offering; ADT to Repurchase 29.1M Shares
ProForm 424B7ADT · Form 424B7 · 6d ago
Cabaletta Bio Secures $141M in Dilutive Offering at Discounted Price, Extends Runway into Mid-2027
ProForm 8-KCABA · Form 8-K · 6d ago
Cabaletta Bio Secures $141M Through Highly Dilutive Stock Offering to Fund Clinical Programs
ProForm 424B5CABA · Form 424B5 · 6d ago
Imunon Seeks Shareholder Approval for Significant Equity Incentive Plan Expansion
ProForm DEF 14AIMNN · Form DEF 14A · 6d ago
Rein Therapeutics Finalizes $50M Public Offering at Deep Discount, Causing Massive Dilution
ProForm 424B5RNTX · Form 424B5 · 6d ago
Sphere 3D Urges Shareholder Vote on Cathedra Merger, Approving Major Dilution & Potential Reverse Split
ProForm DEFA14AANY · Form DEFA14A · 6d ago
CNA Financial Reports Significant Q1 Profit Decline and Worsening Underwriting Performance
ProForm 10-QCNA · Form 10-Q · 6d ago
Aura Biosciences Appoints New CEO, Nears Phase 3 Enrollment Completion, and Halts ATM Sales
ProForm 8-KAURA · Form 8-K · 6d ago
Modiv Industrial to be Acquired by Global Net Lease in $535M All-Stock Merger
ProForm 425MDV · Form 425 · 6d ago
MODIV INDUSTRIAL to be Acquired by Global Net Lease in $535M All-Stock Transaction at 17% Premium
ProForm 8-KMDV · Form 8-K · 6d ago
Global Net Lease to Acquire Modiv Industrial in $535M All-Stock, Leverage-Neutral Transaction
ProForm 8-KGNL · Form 8-K · 6d ago